180 Life Sciences Announces Completion of Transaction with KBLM Merger Corp IV
November 10, 2020 11:46 ET
|
180 Life Sciences Corp.
MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...
Innovative Companies with Blockbuster Potential Catch SPAC Attention
October 23, 2020 08:30 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger...
UPDATE -- The Quest for Blockbuster Drugs Continues
October 21, 2020 13:31 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger...
The Quest for Blockbuster Drugs Continues
October 21, 2020 08:30 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ brands in the...
SPACs Show Investors Faster, Simpler Way to Go Public
October 16, 2020 08:30 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio -- 180 Life Sciences Corp. announces the availability of a broadcast titled, “Blockbuster Year and Bright Horizons for SPACs.” To hear...
Promising Biotechs Choosing SPAC for Speed, Capital, Visibility
October 14, 2020 08:30 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 14, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- 180 Life Sciences Corp. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ brands in...
UPDATE: 180 Life Sciences Corp. Expands Intellectual Property Portfolio
October 06, 2020 14:57 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced the signing of a definitive...
180 Life Sciences Corp. Expands Intellectual Property Portfolio
October 06, 2020 14:25 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced the signing of a definitive...
180 Life Science Corp. Announces New Board of Directors Appointments
October 05, 2020 13:00 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced the signing of a definitive...
Development of Next-Generation Drugs to Inhibit Ravages of Chronic Inflammation
October 05, 2020 08:30 ET
|
180 Life Sciences Corp.
NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: KBLM) announces the availability of a broadcast titled, “Solving One of the Largest Drivers of...